Wolfe Research raises Texas Instruments stock price target on growth By Investing.com

Wolfe Research raised its Texas Instruments price target to $315 from $260 while keeping an Outperform rating, citing Q1 revenue that rose 9% sequentially and came in 7% above consensus. The firm lifted 2026/2027 estimates to $21B/$23.8B in revenue and $7.52/$9.12 in EPS, with over $10B of expected 2027 free cash flow; the pending SLAB acquisition should add modestly to EPS and FCF. TI’s shares trade near a 52-week high at $236.31, and multiple other analysts also raised targets after strong data center growth and earnings results.

Analysis

The market is starting to re-rate TXN as a compounder rather than a cyclical analog play, but the bigger implication is a capital-allocation reset across the broader semiconductor complex. If management can sustain high-50s gross margins while datacenter remains a mid-teens mix contributor, the multiple can stay elevated even if industrial demand is only recovering, not accelerating. That creates a second-order winner set in adjacent analog/power names with similar end-market exposure, but it also raises the bar for any supplier still priced on mid-cycle assumptions.

The key risk is that consensus is extrapolating a clean cyclical recovery into what may be a front-loaded demand pull-forward. Industrial normalization tends to look strongest right before pricing and order momentum flatten; if that happens over the next 2-3 quarters, the stock’s premium valuation becomes vulnerable because the market is paying for durable growth, not just better-than-seasonal prints. The SLAB deal helps, but it is not large enough to offset any multiple compression if datacenter growth decelerates or if capex guidance creeps higher.

The market is probably underpricing the duration of the datacenter contribution, but overpricing the certainty of margin stability. A nearly doubled datacenter mix can mask weakness elsewhere for a few quarters, yet it also increases customer concentration and sensitivity to hyperscaler spending cadence. If AI infrastructure spending broadens into industrial edge, the upside is further out than the current rerating implies; if not, TXN becomes a quality-cyclical with a stretched premium.

The cleanest contrarian read is that this is a good business but not necessarily a good entry at current levels. With the stock near highs and valuation already baking in 2027 cash flow, incremental upside likely requires either another upward revision cycle or evidence that the datacenter mix is structurally larger than peers expect. Absent that, the risk/reward is better expressed through relative trades than outright chasing.

Key Decisions for Investors

• Maintain a tactical long TXN only on pullbacks toward the low-220s; above that, upside is likely capped unless next quarter confirms another order/revenue inflection.
• Pair trade: long TXN / short a higher-beta analog peer with weaker datacenter exposure for 1-2 quarters; this isolates the quality premium while reducing cyclicality risk.
• Use call spreads instead of outright stock if initiating new exposure: TXN 6-9 month call spreads to capture another rerating leg while limiting downside if industrial demand stalls.
• Watch for a short opportunity if industrial growth flattens over the next 2 reporting cycles; a miss on revenue mix or gross margin would likely compress the multiple faster than earnings can offset.
• Accumulate SLAB only as a relative-value beneficiary of the acquisition, but size modestly until deal-close timing and synergy realization are clearer.